ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Relative contributions of meteorological factors and atmospheric pollutants to childhood adenoid hypertrophy: A time-series study in Chongqing, China.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdenoid hypertrophy significantly impacts children's health. While respiratory diseases are influenced by air pollution and meteorological factors, their effects on adenoid hypertrophy remain poorly understood.
objectiveTo quantify the effects of meteorological factors and air pollutants on childhood adenoid hypertrophy hospital visits.
methodsWe analyzed 236,438 hospital visits for childhood adenoid hypertrophy (2014-2019, 2023-2024) in children < 18 years in Chongqing, China (2922 observation days) using distributed lag nonlinear models. Environmental exposures were assigned at the district level based on monitoring stations nearest to each patient's residential district. We quantified associations using standardized regression coefficients and attributable disease burdens, examining non-linear exposure-response relationships and seasonal variability. Environmental exposures included six meteorological factors (temperature, atmospheric pressure, humidity, wind speed, sunshine duration, rainfall) and six air pollutants (PM2.5, PM10, NO₂, SO₂, CO, O₃).
resultsOzone demonstrated the largest model-based attributable burden, with an estimated 16,231 cases associated with IQR increases in exposure. Summer showed extraordinary disease concentration (79.5% of cases). These findings provide preliminary evidence for environmental associations with adenoid hypertrophy in subtropical basin settings, with ozone and summer season emerging as key factors.
conclusionThis time-series analysis identified strong environmental associations with childhood adenoid hypertrophy in a subtropical basin setting. Ozone demonstrated the largest model-based association with childhood adenoid hypertrophy hospital visits(16,231 attributable cases, 6.9% of burden), with extraordinary summer disease concentration (79.5% of cases). These findings provide important evidence linking environmental exposures to adenoid hypertrophy patterns, though causal confirmation through future studies would be needed before informing environmental health strategies in comparable subtropical basin regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.